TWiV 959: Clinical update with Dr. Daniel Griffin
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In his weekly clinical update Dr. Griffin discusses effectiveness of influenza vaccination of pregnant women for prevention of maternal and early infant Influenza-associated hospitalizations in South Africa, a multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes, single and 2-dose vaccinations with modified vaccinia Ankara-Bavarian Nordic induce durable B cell memory responses comparable to replicating smallpox vaccines, whether the risk of still and preterm birth is affected by the timing of symptomatic SARS-CoV-2 infection during pregnancy, medical masks versus N95 respirators for preventing COVID-19 among health care workers, alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants, real-world evidence of novel treatments for COVID-19 on mortality: a nationwide comparative cohort study of hospitalized patients in the 1st, 2nd, 3rdand 4th wave in the Netherlands, and effectiveness and safety of extended thromboprophylaxis in post-discharge patients with COVID-19.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Effectiveness of Influenza vaccination in pregnant women (OFID)
- Multivalent nucleoside-modified mRNA vaccine against Influenza subtypes (Science)
- Single and 2-dose vaccinations with modified vaccinia Ankara-Bavarian Nordic (JID)
- Is the risk of still and preterm birth affected by the timing of symptomatic SARS-CoV-2 infection? (AJOG)
- Medical masks versus N95 respirators for preventing COVID-19 among health care workers (ACP)
- Bebtelovimab fact sheet for providers (FDA)
- Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants (bioRxiV)
- Paxlovid patient eligbiliity screening checklist (FDA)
- Real-world evidence of novel treatments for COVID-19 on mortality (OFID)
- Effectiveness and safety of extended thromboprophylaxis in post-discharge patients with COVID-19 (Thrombosis Research)
- Contribute to our MicrobeTV fundraiser at PWB
- Dr. Griffin's treatment guide (pdf)
- Letters read on TWiV 959
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]